Advertisement

Topics

Messe Frankfurt GmbH Company Profile

07:49 EDT 25th September 2018 | BioPortfolio

Within the German Equity Forum Fall 2006 more than 200 listed companies will hold their analyst conference and will present their 3rd quarter results to analysts and institutional investors. The presentations are hosted and moderated by experts of our Main Sponsors.
The timetable of the analyst conferences can be found here

Location

Ludwig-Erhard-Anlage 1
Frankfurt
60327
Germany

Contact

Phone: 49 69 75 75-30 00
Fax: 49 69 75 75-30 01
Email: eigenkapitalforum@deutsche-boerse.com


News Articles [562 Associated News Articles listed on BioPortfolio]

Processing it all, day 1 — some of the key innovations from the show floor at ACHEMA 2018

As thousands of visitors flock to Frankfurt for the world forum and leading show for the process industries, we take a sneaky peek at some of the innovations that will be on offer from exhibitors in t...

MorphoSys-Aktie: MOR106 an Novartis lizensiert - Neubewertungsphase

Frankfurt am Main (www.aktiencheck.de) - MorphoSys-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, bestätigen in einer aktuellen Akti...

Medigene-Aktie: MDG1011-klinische Studie gestartet - Kursziel angehoben, kaufen!

Frankfurt am Main (www.aktiencheck.de) - Medigene-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, raten in einer aktuellen Aktienanal....

Medigene: Erster Erfolgsmeilenstein aus der BLUE-Kooperation

Frankfurt am Main (www.aktiencheck.de) - Medigene-Aktienanalyse der EQUI.TS GmbH: Thomas J. Schießle, Aktienexperte der EQUI.TS GmbH, rät in einer aktuellen Aktienanalyse weiterhin zum Kauf der Akt....

Evotec-Aktie: Neuer Celgene-Deal als Beschleuniger - Kaufenmpfehlung

Frankfurt am Main (www.aktiencheck.de) - Evotec-Aktienanalyse der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienexperten der EQUI.TS GmbH, raten in einer aktuellen Aktienanalyse wei....

BRAIN-Aktie: Q2/2018 etwas besser - warten auf mehr Wachstum

Frankfurt am Main (www.aktiencheck.de) - BRAIN-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, raten in einer aktuellen Aktienanalyse....

Die Gree AI Multi VRF Unit GMV6 war auf der Canton-Messe der große Hit

Im Rahmen der Werbeveranstaltung auf der Canton-Messe führte Herr Ouyang Jun, Stellvertretender Geschäftsführer der Gree Overseas Sales Company, weiter aus, dass die GMV6 dank einer Read more.....

Evotec-Aktie bleibt ein Kauf, Q1/18 mit gutem Start, Akquisitionen liefern

Frankfurt am Main - Evotec-Aktienanalyse von Analysten Thomas J. Schießle und Daniel Großjohann von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Analysten der EQUI.TS GmbH, raten in...

PubMed Articles [19 Associated PubMed Articles listed on BioPortfolio]

18th Experts Meeting Parkinson in Frankfurt / Main.

The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience.

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Correction: Health Impact of the Heatwave of 2015: Hospital Admissions in Frankfurt/Main, Germany.

Health Impact of the Heatwave of 2015: Hospital Admissions in Frankfurt/Main, Germany.

Heatwaves are gaining in importance due to increasing climatic changes. They can impair health and increase mortality. A comparison of studies is difficult because of differences in the definition of ...

Clinical Trials [51 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study

Prospective observational multicenter study to evaluate copeptin as a prognostic marker in patients with an acute cerebrovascular event. It includes four groups of patients, mainly dependi...

R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Purpose: to evaluate an efficacy of chemotherapy regimens R-DA-EPOCH-21 and R-mNHL-BFM-90 with and without autologous hematopoietic stem cells transplantation (auto-SCT) in newly diagnosed...

Companies [580 Associated Companies listed on BioPortfolio]

Messe Frankfurt GmbH

Within the German Equity Forum Fall 2006 more than 200 listed companies will hold their analyst conference and will present their 3rd quarter results to analysts and institutional investors. The prese...

PharmaNet GmbH (Frankfurt Office)

Global full service provider in clinical drug development

GYMWATCH GmbH

GYMWATCH GmbH develops advanced fitness technologies and devices. Based in Darmstadt, Germany, near Frankfurt, the company’s first product is the patented GYMWATCH Sensor, wh...

Messe Dusseldorf North America

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

More Information about "Messe Frankfurt GmbH" on BioPortfolio

We have published hundreds of Messe Frankfurt GmbH news stories on BioPortfolio along with dozens of Messe Frankfurt GmbH Clinical Trials and PubMed Articles about Messe Frankfurt GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Messe Frankfurt GmbH Companies in our database. You can also find out about relevant Messe Frankfurt GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record